{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:17:03Z","timestamp":1789208223040,"version":"build-2803163510"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Science, Technology and Innovation (STI) Secretariat through the Office of the President (OP) of Uganda"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Adenovirus vectors have been used for vaccine development, gene therapy, among others, because of their ease of genetic manipulation and high efficiency in delivering and expressing genes in mammalian cells without causing significant cytotoxicity or integrating into the host genome. Adenovirus vectors are relatively immunogenic, hence avoiding the need for adjuvant when used in vaccine design, unlike other vaccine development platforms. Human adenovirus serotype 5 (HAdV-5) has traditionally been employed in vaccine platforms; however, its clinical utility is limited by widespread pre-existing immunity in human populations, which can reduce vaccine efficacy. As a promising alternative, canine adenovirus type 2 (CAV-2) vector offers several advantages, including low seroprevalence in humans, efficient infection of respiratory epithelial and neuronal cells, and long-lasting transgene expression. These features render the CAV-2 vector particularly suitable for vaccine applications requiring repeated administrations or booster doses. In this protocol, we describe methods for the expression, expansion, purification, and titration of a non-replicative CAV-2 vector in the AD-293 cell line. The procedure involves the release of the recombinant viral genome from the pUC19 plasmid backbone, followed by virus stock expansion in a complementing AD-293 cell line, which is able to express the E1 protein to aid virus replication. The virus stock was purified through ion-exchange liquid chromatography and titered using the Improved K\u00e4rber method. This work contributes to the growing field of alternative adenoviral vectors with implications for translational research by providing step-by-step procedures for producing a canine adenovirus type 2 (CAV-2) vector.<\/jats:p>","DOI":"10.1371\/journal.pone.0341642","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:52:01Z","timestamp":1779299521000},"page":"e0341642","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practical guidelines for producing non-replicating canine adenovirus vectors"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-1754","authenticated-orcid":true,"given":"Denis","family":"Omara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ndekezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mugaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angella","family":"Nakyanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Bukenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Bwogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-497X","authenticated-orcid":true,"given":"Fortunate","family":"Natwijuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kapaata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drake","family":"Byamukama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy Lorna","family":"Ayebale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Patrick","family":"Kateete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6672-3688","authenticated-orcid":true,"given":"Jennifer","family":"Serwanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sande James","family":"Obondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Nina","family":"Balinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"3","key":"pone.0341642.ref001","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.analchem.1c02439","article-title":"Analysis of Recombinant Adenovirus Vectors by Ion Trap Charge Detection Mass Spectrometry: Accurate Molecular Weight Measurements beyond 150 MDa","volume":"94","author":"LF Barnes","year":"2022","journal-title":"Anal Chem"},{"issue":"9","key":"pone.0341642.ref002","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/v2092134","article-title":"An update on canine adenovirus type 2 and its vectors","volume":"2","author":"T Bru","year":"2010","journal-title":"Viruses"},{"issue":"7","key":"pone.0341642.ref003","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12275-024-00159-4","article-title":"Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses","volume":"62","author":"A Park","year":"2024","journal-title":"J Microbiol"},{"issue":"10","key":"pone.0341642.ref004","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what\u2019s important?","volume":"10","author":"H Fausther-Bovendo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"pone.0341642.ref005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs","volume":"24","author":"J Alonso-Padilla","year":"2016","journal-title":"Mol Ther"},{"key":"pone.0341642.ref006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fnmol.2019.00071","article-title":"CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems","volume":"12","author":"D Del Rio","year":"2019","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"pone.0341642.ref007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1385\/MB:34:2:247","article-title":"The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy","volume":"34","author":"M Perreau","year":"2006","journal-title":"Mol Biotechnol"},{"issue":"11","key":"pone.0341642.ref008","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/genes13112129","article-title":"HEHR: Homing Endonuclease-Mediated Homologous Recombination for Efficient Adenovirus Genome Engineering","volume":"13","author":"K Schr\u00f6er","year":"2022","journal-title":"Genes (Basel)"},{"issue":"6","key":"pone.0341642.ref009","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"M Robert-Guroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"pone.0341642.ref010","doi-asserted-by":"crossref","DOI":"10.4110\/in.2021.21.e6","article-title":"Adenovirus Vectors: Excellent Tools for Vaccine Development","volume":"21","author":"J Chang","year":"2021","journal-title":"Immune Netw"},{"issue":"5","key":"pone.0341642.ref011","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/v14050888","article-title":"Cytokine Responses to Adenovirus and Adenovirus Vectors","volume":"14","author":"S Atasheva","year":"2022","journal-title":"Viruses"},{"issue":"18","key":"pone.0341642.ref012","first-page":"5260","article-title":"Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection","volume":"62","author":"G Miller","year":"2002","journal-title":"Cancer Res"},{"key":"pone.0341642.ref013","doi-asserted-by":"crossref","first-page":"854690","DOI":"10.3389\/fmicb.2022.854690","article-title":"Rescue of Recombinant Adenoviruses by CRISPR\/Cas-Mediated in vivo Terminal Resolution","volume":"13","author":"A Riedl","year":"2022","journal-title":"Front Microbiol"},{"issue":"184","key":"pone.0341642.ref014","article-title":"Construction of Adenoviral Vectors using DNA Assembly Technology","author":"X Zou","year":"2022","journal-title":"J Vis Exp"},{"issue":"3","key":"pone.0341642.ref015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors","volume":"109","author":"MG Cottingham","year":"2012","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"pone.0341642.ref016","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1002\/bit.27918","article-title":"Design of transfections: Implementation of design of experiments for cell transfection fine tuning","volume":"118","author":"S Mancinelli","year":"2021","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"pone.0341642.ref017","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/btpr.25","article-title":"Towards purification of adenoviral vectors based on membrane technology","volume":"24","author":"C Peixoto","year":"2008","journal-title":"Biotechnol Prog"},{"key":"pone.0341642.ref018","doi-asserted-by":"crossref","first-page":"114305","DOI":"10.1016\/j.jviromet.2021.114305","article-title":"Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology","volume":"299","author":"S Suleman","year":"2022","journal-title":"J Virol Methods"},{"key":"pone.0341642.ref019","volume-title":"Rapid Adenovirus Purification Using Q Sepharose XL. Poster presented at the ESGT","author":"K Eriksson","year":"2000"},{"issue":"7","key":"pone.0341642.ref020","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/bit.29006","article-title":"Integrating Affinity Chromatography in the Platform Process for Adenovirus Purification","volume":"122","author":"Y Wu","year":"2025","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"pone.0341642.ref021","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12665\/J11.Sosnowski","article-title":"Development of a stable adenoviral vector formulation","volume":"1","author":"D Hoganson","year":"2002","journal-title":"Bioprocess J"},{"issue":"1","key":"pone.0341642.ref022","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the Calculation of TCID50 for Quantitation of Virus Infectivity","volume":"36","author":"C Lei","year":"2021","journal-title":"Virol Sin"},{"issue":"3","key":"pone.0341642.ref023","article-title":"Lipid-based Transfection Reagents Exhibit Cryo-induced Increase in Transfection Efficiency","volume":"5","author":"H Sork","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"pone.0341642.ref024","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2009.11.021","article-title":"Developing adenoviral vectors encoding therapeutic genes toxic to host cells: comparing binary and single-inducible vectors expressing truncated E2F-1","volume":"397","author":"JG Gomez-Gutierrez","year":"2010","journal-title":"Virology"},{"issue":"10","key":"pone.0341642.ref025","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy","volume":"21","author":"A Ricobaraza","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0341642.ref026","article-title":"Release of the Cloned Recombinant Adenovirus Genome for Rescue and Expansion","volume":"2019","author":"Q Su","year":"2019","journal-title":"Cold Spring Harb Protoc"},{"issue":"1","key":"pone.0341642.ref027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.cgt.7700769","article-title":"ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis","volume":"12","author":"CO Yun","year":"2005","journal-title":"Cancer gene therapy"},{"issue":"5","key":"pone.0341642.ref028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/mthe.2000.0212","article-title":"Multiplicity of infection\/multiplicity of confusion","volume":"2","author":"P Shabram","year":"2000","journal-title":"Mol Ther"},{"key":"pone.0341642.ref029","first-page":"415","article-title":"Chromatographic purification of virus particles","volume-title":"Downstream Industrial Biotechnology: Recovery and Purification","author":"P Gagnon","year":"2013"},{"key":"pone.0341642.ref030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-61779-095-9_4","article-title":"Overview of current scalable methods for purification of viral vectors","volume-title":"Viral Vectors for Gene Therapy: Methods and Protocols","author":"MM Segura","year":"2011"},{"issue":"11","key":"pone.0341642.ref031","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jgm.1383","article-title":"Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography","volume":"11","author":"MN Eglon","year":"2009","journal-title":"J Gene Med"},{"key":"pone.0341642.ref032","article-title":"Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques","author":"AM Duffy","year":"2005","journal-title":"Gene Ther"},{"issue":"8","key":"pone.0341642.ref033","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00253-016-8071-x","article-title":"A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles","volume":"101","author":"B Leuchs","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"pone.0341642.ref034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jviromet.2007.08.015","article-title":"A highly sensitive and versatile virus titration assay in the 96-well microplate format","volume":"147","author":"V Borisevich","year":"2008","journal-title":"J Virol Methods"},{"issue":"10","key":"pone.0341642.ref035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/hum.2014.151","article-title":"miR-145 Is a Promising Therapeutic Target to Prevent Cornea Scarring","volume":"26","author":"D Ratuszny","year":"2015","journal-title":"Hum Gene Ther"},{"key":"pone.0341642.ref036","first-page":"1","article-title":"Penium margaritaceum as a model organism for cell wall analysis of expanding plant cells","volume-title":"Plant Cell Expansion: Methods and Protocols","author":"MG Rydahl","year":"2014"},{"key":"pone.0341642.ref037","doi-asserted-by":"crossref","first-page":"107370","DOI":"10.1016\/j.biotechadv.2019.03.009","article-title":"Neural tissue engineering with structured hydrogels in CNS models and therapies","volume":"42","author":"J George","year":"2020","journal-title":"Biotechnol Adv"},{"issue":"6","key":"pone.0341642.ref038","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/gt.2014.30","article-title":"Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H","volume":"21","author":"Y Inaguma","year":"2014","journal-title":"Gene Ther"},{"key":"pone.0341642.ref039","volume-title":"NIH guidelines for research involving recombinant DNA molecules","author":"Health NIo","year":"2002"},{"issue":"4","key":"pone.0341642.ref040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention","volume":"37","author":"JP Lynch","year":"2016","journal-title":"Semin Respir Crit Care Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:52:07Z","timestamp":1779299527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341642"}},"subtitle":[],"editor":[{"given":"Roland","family":"Zahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341642","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}